Slow acetylator genotypes as a possible risk factor for infectious mononucleosis-like syndrome induced by salazosulfapyridine

British Journal of Dermatology

Volumn 148, Issue 5, 2003, Pages 1035-1039

  Ohtani, Toshio ^a   Hiroi, A ^a   Sakurane, M ^a   Furukawa, F ^a  

^a WAKAYAMA MEDICAL UNIVERSITY   (Japan)

Author keywords

Infectious mononucleosis like syndrome; N acetyltransferase 2; Polymerase chain reaction restriction fragment length polymorphism; Salazosulfapyridine; Slow acetylator

Indexed keywords

ACYLTRANSFERASE; ARYLAMINE ACETYLTRANSFERASE; METHYLPREDNISOLONE; PREDNISONE; SALAZOSULFAPYRIDINE; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CASE REPORT; CLINICAL ARTICLE; CLINICAL FEATURE; DISEASE COURSE; DISEASE SEVERITY; DOSE RESPONSE; DRUG ACETYLATION; DRUG HYPERSENSITIVITY; DRUG METABOLISM; FEMALE; FEVER; GENOTYPE; HIGH RISK POPULATION; HUMAN; HUMAN TISSUE; INFECTIOUS MONONUCLEOSIS LIKE SYNDROME; LIVER DYSFUNCTION; LYMPHOCYTE COUNT; MALE; PHENOTYPE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RASH; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; RISK FACTOR; ULCERATIVE COLITIS;

ACETYLATION; ADULT; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ARYLAMINE N-ACETYLTRANSFERASE; CASE-CONTROL STUDIES; DRUG ERUPTIONS; FEMALE; GENOTYPE; HUMANS; INFLAMMATORY BOWEL DISEASES; MALE; MIDDLE AGED; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; SULFASALAZINE;

EID: 0037863063     PISSN: 00070963     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2133.2003.05321.x     Document Type: Article

References (17)

1. Peppercorn MA. Sulfasalazine, Pharmacology, clinical use, toxicity, and related new drug development. Ann Intern Med 1984; 101: 377-86.
2. Klotz U. Clinical pharmacokinetics of sulphasalazine, its metabolites and other prodrugs of 5-aminosalicylic acid. Clin Pharmacokinet 1985; 10: 285-302.
3. Meyer UA, Zanger UM, Skoda RC et al. Genetic polymorphisms of drug metabolism. Prog Liver Dis 1990; 9: 307-23.
4. Azad Khan AK, Nurazzaman M, Truelove SC. The effect of the acetylator phenotype on the metabolism of sulphasalazine in man. J Med Genet 1983; 20: 30-6.
5. Deguchi T, Mashimo M, Suzuki T. Correlation between acetylator phenotypes and genotypes of polymorphic arylamine N-acetyltransferase in human liver. J Biol Chem 1990; 265: 12757-60.
6. Mashimo M, Suzuki T, Abe M, Deguchi T. Molecular genotyping of N-acetylation polymorphism to predict phenotype. Hum Genet 1992; 90: 139-43.
7. Abe M, Deguchi T, Suzuki T. The structure and characteristics of a fourth allele of polymorphic N-acetyltransferase gene found in the Japanese population. Biochem Biophys Res Commun 1993; 191: 811-16.
8. Sekine A, Saito S, Iida A et al. Identification of single-nucleotide polymorphisms (SNPs) of human N-acetyltransferase genes NAT1, NAT2, AANAT, ARD1, and L1CAM in the Japanese population. J Hum Genet 2001; 46: 314-19.
9. Martinez C, Agundez JA, Olivera M et al. Lung cancer and mutations at the polymorphic NAT2 gene locus. Pharmacogenetics 1995; 5: 207-14.
10. Okumura K, Kita T, Chikazawa S et al. Genotyping of N-acetylation polymorphism and correlation with procainamide metabolism. Clin Pharmacol Ther 1997; 61: 509-17.
11. Ohno M, Yamaguchi I, Yamamoto I et al. Slow N-acetyltransferase 2 genotype affects the incidence of isoniazid and rifampicin-induced hepatotoxicity. Int J Tuberc Lung Dis 2000; 4: 256-61.
12. Tanigawara Y, Kita T, Aoyama N et al. N-acetyltansferase 2 genotype-related sulfapyridine acetylation and its adverse events. Biol Pharm Bull 2002; 25: 1058-62.
13. Gunnarsson I, Kanerud L, Pettersson E et al. Predisposing factors in sulphasalazine-induced systemic lupus erythematosus. Br J Rheumatol 1997; 36: 1089-94.
14. Descamps V, Bouscarat F, Laglenne S et al. Human herpesvirus 6 infection associated with anticonvulsant hypersensitivity syndrome and reactive haemophagocytic syndrome. Br J Dermatol 1997; 137: 605-8.
15. Suzuki Y, Inagi R, Aono T et al. Human herpesvirus 6 infection as a risk factor for the development of severe drug-induced hypersensitivity syndrome. Arch Dermatol 1998; 134: 1108-12.
16. Tohyama M, Yahata Y, Yasukawa M et al. Severe hypersensitivity syndrome due to sulfasalazine associated with reactivation of human herpesvirus 6. Arch Dermatol 1998; 134: 1113-17.
17. Shear NH, Spielberg SP. Anticonvulsant hypersensitivity syndrome. J Clin Invest 1988; 82: 1826-32.